[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pernix Therapeutics Holdings, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

February 2018 | 69 pages | ID: P436A2F4030EN
MarketLine

US$ 350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Pernix Therapeutics Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketline's Pernix Therapeutics Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Pernix Therapeutics Holdings, Inc. since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Pernix Therapeutics Holdings, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Pernix Therapeutics Holdings, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope
  • Provides intelligence on Pernix Therapeutics Holdings, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
  • Detailed reports of various financial transactions undertaken by Pernix Therapeutics Holdings, Inc. and its subsidiaries since 2007.
  • Information about key financial and legal advisors for Pernix Therapeutics Holdings, Inc.'s financial deals transactions.
  • Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
  • Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
  • Form an independent opinion about Pernix Therapeutics Holdings, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
  • Track your competitors’ business structure and growth strategies.
COMPANY OVERVIEW AND KEY FACTS

TABLE OF CONTENTS

LIST OF TABLES

LIST OF FIGURES

TARGETS AND PARTNERS

MERGERS & ACQUISITIONS

Mergers and Acquisitions - Overview
Mergers and Acquisitions - Deal reports

PARTNERSHIP

Partnership - Deal reports

CAPITAL RAISING

Capital Raising - Overview
Capital Raising - Deal reports

APPENDIX

Contact Us
About MarketLine Financial Deals Database
Deal Definition and Methodology
About MarketLine

LIST OF TABLES

Table 1: Argos Therapeutics partnership volume and value trend (2014-YTD2018)
Table 2: Argos Therapeutics partnership trend by key deal type (2014-YTD2018)
Table 3: Argos Therapeutics capital raising volume and value trend (2014-YTD2018)
Table 4: Argos Therapeutics capital raising by deal type (2014-YTD2018)

LIST OF FIGURES

Figure 1: Janssen Biotech partnership volume and value trend (2014-YTD2018)
Figure 2: Janssen Biotech partnership trend by key deal type (2014-YTD2018)


More Publications